Clinical Trials Logo

Filter by:
NCT ID: NCT06071325 Completed - Clinical trials for Diabetes Mellitus, Type 2

Green Digital Diabetes Waste Project

Start date: September 19, 2023
Phase:
Study type: Observational

The purpose of this study is to determine how people with diabetes are disposing of various products and devices and at what rates so that better devices with less waste can be designed in the future.

NCT ID: NCT06069713 Completed - Perceptions Clinical Trials

Consumer Perceptions of Cannabidiol (CBD) Health Claims

CBD
Start date: October 9, 2023
Phase: N/A
Study type: Interventional

Over 46 million US adults report use of cannabidiol (CBD), primarily to treat medical ailments. The growing CBD market spans the range of products that the US Food and Drug Administration (FDA) regulates including drugs, dietary supplements, food/beverages and cosmetics. CBD cannot be marketed as having therapeutic benefits (without FDA's approval), be false or misleading to consumers, or convey the products are approved or endorsed by the FDA. In addition, CBD cannot be marketed as a food additive or dietary supplement since it is an active ingredient in an approved drug, Epidiolex. Despite this, CBD products have been illicitly advertised to consumers with these claims including unsubstantiated health claims that promote benefits including curing cancer and preventing Alzheimer's disease. These types of claims may reduce perceptions of harm and increase perceived benefits of use. This study aims to evaluate how consumers perceive real-world CBD advertisements. To that end, we will implement an online survey and randomize adult participants (ages 18-65) to see various advertisements made about CBD to determine if they interpret advertisements as making health claims that are currently prohibited by the FDA.

NCT ID: NCT06069609 Completed - Astigmatism Clinical Trials

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Acuvue Oasys 1-Day for Astigmatism Contact Lenses

Start date: August 11, 2023
Phase: N/A
Study type: Interventional

Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double-masked (subject and investigator), repeated measures insertion study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria, subjects will be dispensed study lenses according to unique randomization tables that will be provided to each Investigator. If study eligibility is met, subjects will have lenses inserted in random, successive order. Subjects will be receiving each of the study lens types once, in a randomized order. The subject will wear each of the study contact lenses for approximately 10 minutes.

NCT ID: NCT06069271 Completed - Exercise Training Clinical Trials

Kettlebell Swings and Paraspinal Muscle Function

Start date: March 4, 2020
Phase: N/A
Study type: Interventional

The purpose of this randomized control trial is to determine the extent of muscle fatigue in the lumbar erector spinae musculature secondary to a high-intensity interval kettlebell swing protocol utilizing TMG previously published by Jay et. al in 2011.

NCT ID: NCT06069245 Completed - Healthy Clinical Trials

MitoQ & Cardiopulmonary Responses During Exercise

Start date: September 14, 2022
Phase: N/A
Study type: Interventional

Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy expenditure and fat/carbohydrate oxidation during sub maximal exercise. In a double-blind, randomized, placebo controlled, cross-over study design, participants performed 2 experimental trials which differed only in the supplement consumed (MitoQ or Placebo). Participants performed identical exercise protocols which consisted of a series of submaximal workloads followed by a ramp protocol to volitional exhaustion.

NCT ID: NCT06068972 Completed - Clinical trials for Non-Healing Ulcer of Skin

Retrospective Database Review at LTC and SNFs

Start date: April 20, 2022
Phase:
Study type: Observational

The goal of this observational study is to compare the differences in wound outcomes when the MolecuLight imaging procedure is used in combination with standard of care wound assessment in long term care and skilled nursing facilities. The main outcome studied is healing of ulcers after 12-weeks, along with other outcomes such as occurrence of infection, complications, and antimicrobial use. Medical records from the past were reviewed, where patients receiving the MolecuLight procedure were compared to those who did not.

NCT ID: NCT06068712 Completed - Healthy Clinical Trials

Proactive and Reactive Attention to Negative Templates

Start date: October 11, 2014
Phase: N/A
Study type: Interventional

EEG Measures during Visual Search Task. In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue. Note: This is a re-analysis of previously collected data.

NCT ID: NCT06068699 Completed - Adherence, Patient Clinical Trials

Postcards to Improve Remote Monitoring Adherence Among Veterans

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

We tested the effect of informational postcards on improving remote monitoring adherence among Veterans with pacemakers and implantable cardioverter-defibrillators in a stepped-wedge randomized controlled trial.

NCT ID: NCT06067568 Completed - Healthy Volunteers Clinical Trials

Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants

Start date: September 28, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the bioavailability of two different formulations of lutikizumab, and to assess adverse events (AEs) and how lutikizumab moves through the body in healthy Chinese participants.

NCT ID: NCT06067126 Completed - Overweight Clinical Trials

Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention

PrepareD
Start date: April 3, 2019
Phase:
Study type: Observational

The goal of PrepareD is to examine whether the prepregnancy weight-loss intervention administered during the Prepare trial [NCT02346162] has an influence in the postnatal period. PrepareD is a cohort study (no intervention) that will address new specific aims through one in-person visit with mothers and children, dietary recalls, actigraphy, and the use of medical record weights. The goal is to collect data when the child is 3 years old. However, due to the COVID-19 pandemic, the investigators expanded the data collection window in order to collect data up to when the child is 5 years old. The investigators hypothesize that intervening on women before pregnancy is the key to breaking the multigenerational cycle of obesity.